Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium
- PMID: 21681796
- PMCID: PMC3122147
- DOI: 10.1002/ana.22403
Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium
Abstract
Objective: White matter hyperintensities (WMHs) detectable by magnetic resonance imaging are part of the spectrum of vascular injury associated with aging of the brain and are thought to reflect ischemic damage to the small deep cerebral vessels. WMHs are associated with an increased risk of cognitive and motor dysfunction, dementia, depression, and stroke. Despite a significant heritability, few genetic loci influencing WMH burden have been identified.
Methods: We performed a meta-analysis of genome-wide association studies (GWASs) for WMH burden in 9,361 stroke-free individuals of European descent from 7 community-based cohorts. Significant findings were tested for replication in 3,024 individuals from 2 additional cohorts.
Results: We identified 6 novel risk-associated single nucleotide polymorphisms (SNPs) in 1 locus on chromosome 17q25 encompassing 6 known genes including WBP2, TRIM65, TRIM47, MRPL38, FBF1, and ACOX1. The most significant association was for rs3744028 (p(discovery) = 4.0 × 10(-9) ; p(replication) = 1.3 × 10(-7) ; p(combined) = 4.0 × 10(-15) ). Other SNPs in this region also reaching genome-wide significance were rs9894383 (p = 5.3 × 10(-9) ), rs11869977 (p = 5.7 × 10(-9) ), rs936393 (p = 6.8 × 10(-9) ), rs3744017 (p = 7.3 × 10(-9) ), and rs1055129 (p = 4.1 × 10(-8) ). Variant alleles at these loci conferred a small increase in WMH burden (4-8% of the overall mean WMH burden in the sample).
Interpretation: This large GWAS of WMH burden in community-based cohorts of individuals of European descent identifies a novel locus on chromosome 17. Further characterization of this locus may provide novel insights into the pathogenesis of cerebral WMH.
Copyright © 2011 American Neurological Association.
Figures


Comment in
-
Uncovering the genetic architecture of white matter disease.Ann Neurol. 2011 Jun;69(6):907-8. doi: 10.1002/ana.22460. Ann Neurol. 2011. PMID: 21681793 No abstract available.
Similar articles
-
17q25 Locus is associated with white matter hyperintensity volume in ischemic stroke, but not with lacunar stroke status.Stroke. 2013 Jun;44(6):1609-15. doi: 10.1161/STROKEAHA.113.679936. Epub 2013 May 14. Stroke. 2013. PMID: 23674528 Free PMC article.
-
Genome-wide genotyping demonstrates a polygenic risk score associated with white matter hyperintensity volume in CADASIL.Stroke. 2014 Apr;45(4):968-72. doi: 10.1161/STROKEAHA.113.004461. Epub 2014 Feb 27. Stroke. 2014. PMID: 24578207
-
Genes from a translational analysis support a multifactorial nature of white matter hyperintensities.Stroke. 2015 Feb;46(2):341-7. doi: 10.1161/STROKEAHA.114.007649. Epub 2015 Jan 13. Stroke. 2015. PMID: 25586835 Free PMC article.
-
Genetics of age-related white matter lesions from linkage to genome wide association studies.J Neurol Sci. 2012 Nov 15;322(1-2):82-6. doi: 10.1016/j.jns.2012.06.016. Epub 2012 Jul 15. J Neurol Sci. 2012. PMID: 22795385 Free PMC article. Review.
-
Cerebral white matter hyperintensities in the prediction of cognitive decline and incident dementia.Int Rev Psychiatry. 2013 Dec;25(6):686-98. doi: 10.3109/09540261.2013.838151. Int Rev Psychiatry. 2013. PMID: 24423222 Free PMC article. Review.
Cited by
-
The association between higher order abilities, processing speed, and age are variably mediated by white matter integrity during typical aging.Neuropsychologia. 2013 Jul;51(8):1435-44. doi: 10.1016/j.neuropsychologia.2013.03.005. Epub 2013 Mar 16. Neuropsychologia. 2013. PMID: 23507612 Free PMC article.
-
Genetic and Environmental Effects on the Development of White Matter Hyperintensities in a Middle Age Twin Population.Medicina (Kaunas). 2022 Oct 10;58(10):1425. doi: 10.3390/medicina58101425. Medicina (Kaunas). 2022. PMID: 36295585 Free PMC article.
-
Dysexecutive and amnesic AD subtypes defined by single indicator and modern psychometric approaches: relationships with SNPs in ADNI.Brain Imaging Behav. 2012 Dec;6(4):649-60. doi: 10.1007/s11682-012-9207-y. Brain Imaging Behav. 2012. PMID: 23161456 Free PMC article.
-
WW domain binding protein 2 (WBP2) as an oncogene in breast cancer: mechanisms and therapeutic prospects-a narrative review.Gland Surg. 2022 Dec;11(12):1984-2002. doi: 10.21037/gs-22-716. Gland Surg. 2022. PMID: 36654949 Free PMC article. Review.
-
Current pathophysiological concepts in cerebral small vessel disease.Front Aging Neurosci. 2014 Mar 24;6:24. doi: 10.3389/fnagi.2014.00024. eCollection 2014. Front Aging Neurosci. 2014. PMID: 24715862 Free PMC article. Review.
References
-
- Longstreth WT., Jr Brain vascular disease overt and covert. Stroke. 2005;36:2062–2063. - PubMed
-
- Launer LJ. Epidemiology of white matter lesions. Top Magn Reson Imaging. 2004;15:365–367. - PubMed
-
- Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke. 1997;28:652–659. - PubMed
-
- Atwood LD, Wolf PA, Heard-Costa NL, et al. Genetic variation in white matter hyperintensity volume in the Framingham Study. Stroke. 2004;35:1609–1613. - PubMed
-
- Carmelli D, DeCarli C, Swan GE, et al. Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. Stroke. 1998;29:1177–1181. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- N01 HC055016/HL/NHLBI NIH HHS/United States
- R01 NS017950/NS/NINDS NIH HHS/United States
- R01 AG016495/AG/NIA NIH HHS/United States
- N01 HC055020/HL/NHLBI NIH HHS/United States
- DK063491/DK/NIDDK NIH HHS/United States
- N01 HC045133/HC/NHLBI NIH HHS/United States
- N01 HC035129/HC/NHLBI NIH HHS/United States
- R01 AG031287/AG/NIA NIH HHS/United States
- UL1RR025005/RR/NCRR NIH HHS/United States
- U01-HG004402/HG/NHGRI NIH HHS/United States
- N01-HC-25195/HC/NHLBI NIH HHS/United States
- N01 AG012100/AG/NIA NIH HHS/United States
- N01 HC055019/HL/NHLBI NIH HHS/United States
- UL1 RR025005/RR/NCRR NIH HHS/United States
- U01 HL080295/HL/NHLBI NIH HHS/United States
- N01-HC-55022/HC/NHLBI NIH HHS/United States
- N01 HC055021/HL/NHLBI NIH HHS/United States
- N01 HC015103/HC/NHLBI NIH HHS/United States
- N01 HC085086/HL/NHLBI NIH HHS/United States
- N01-HC-55016/HC/NHLBI NIH HHS/United States
- N01 HC055015/HL/NHLBI NIH HHS/United States
- AG033193/AG/NIA NIH HHS/United States
- R01 HL087652/HL/NHLBI NIH HHS/United States
- R01 AG040282/AG/NIA NIH HHS/United States
- N01-HC-55021/HC/NHLBI NIH HHS/United States
- HHSN268200625226C/PHS HHS/United States
- U01 HG004402/HG/NHGRI NIH HHS/United States
- N01-HC-85086/HC/NHLBI NIH HHS/United States
- R01-HL087641/HL/NHLBI NIH HHS/United States
- R01 HL093029/HL/NHLBI NIH HHS/United States
- NS17950/NS/NINDS NIH HHS/United States
- R01-HL087652/HL/NHLBI NIH HHS/United States
- P 20545/FWF_/Austrian Science Fund FWF/Austria
- AG08122/AG/NIA NIH HHS/United States
- P30 DK063491/DK/NIDDK NIH HHS/United States
- R01 AG008122/AG/NIA NIH HHS/United States
- N01-HC-55019/HC/NHLBI NIH HHS/United States
- M01RR00425/RR/NCRR NIH HHS/United States
- N01 HC025195/HL/NHLBI NIH HHS/United States
- R01 AG033193/AG/NIA NIH HHS/United States
- N01-HC-55015/HC/NHLBI NIH HHS/United States
- N01 HC055222/HL/NHLBI NIH HHS/United States
- N01-HC-55222/HC/NHLBI NIH HHS/United States
- R01-HL093029/HL/NHLBI NIH HHS/United States
- N01 HC085079/HL/NHLBI NIH HHS/United States
- N01-HC-75150/HC/NHLBI NIH HHS/United States
- N01-HC-55020/HC/NHLBI NIH HHS/United States
- AG031287/AG/NIA NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
- N01 HC055018/HL/NHLBI NIH HHS/United States
- M01 RR000425/RR/NCRR NIH HHS/United States
- AG16495/AG/NIA NIH HHS/United States
- N01-HC-85079/HC/NHLBI NIH HHS/United States
- N01 HC055022/HL/NHLBI NIH HHS/United States
- K23 AG038444/AG/NIA NIH HHS/United States
- P30 AG010129/AG/NIA NIH HHS/United States
- N01 HC075150/HL/NHLBI NIH HHS/United States
- N01-HC-55018/HC/NHLBI NIH HHS/United States
- R01 HL087641/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources